SCREENING AND LEAD-IN OBSERVATIONAL PROTOCOL TO DETERMINE POTENTIAL PATIENT ELIGIBILITY FOR INCLUSION IN AAV GENE THERAPY CLINICAL TRIALS IN HAEMOPHILIA B (ECLIPSE).
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
FREELINE THERAPEUTICS LTD
Cita
SCREENING AND LEAD-IN OBSERVATIONAL PROTOCOL TO DETERMINE POTENTIAL PATIENT ELIGIBILITY FOR INCLUSION IN AAV GENE THERAPY CLINICAL TRIALS IN HAEMOPHILIA B (ECLIPSE). (FLT-01). FREELINE THERAPEUTICS LTD. 2020-2025. IP:ANA ROSA CID HARO.
Portal de investigación